Charles River Laboratories International Inc
CRL166.910USD
-2.730-1.61%
收盘 08/01, 16:00（美东）报价延迟15分钟
8.20B总市值
亏损市盈率 TTM
关于 Charles River Laboratories International Inc 公司
Charles River Laboratories International, Inc. 提供基本产品和服务，帮助全球制药和生物技术公司、政府机构和学术机构加速其研究和药物开发工作。该公司的研究模型和服务部门由三项业务组成，提供基础工具，使其客户能够发现新分子：研究模型、研究模型服务和细胞解决方案。其发现和安全评估部门提供受监管和非受监管的 DSA 服务，以支持潜在新药的研究、开发和监管要求的安全测试，包括治疗发现和优化以及体外和体内研究、实验室支持服务以及战略非临床咨询和项目管理，以支持产品开发。其制造解决方案部门包括微生物解决方案和生物制剂解决方案。
公司简介
公司代码CRL
公司名称Charles River Laboratories International Inc
上市日期Jun 23, 2000
成立日期1994
CEOMr James C. Foster
员工数量18600
证券类型Ordinary Share
年结日Jun 23
公司地址251 Ballardvale St
城市WILMINGTON
上市交易所NYSE Consolidated
国家United States of America
邮编01887
电话17812226000
网址https://www.criver.com/
公司代码CRL
上市日期Jun 23, 2000
成立日期1994
公司高管
名称
名称/职务
职务
持股
持股变动
Mr James C. Foster
Mr James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
13.68K
-2.74%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
12.88K
+69.56%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Independent Director
Independent Director
3.96K
+31.35%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
2.59K
+155.42%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
2.41K
+64.49%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
946.00
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr James C. Foster
Mr James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
13.68K
-2.74%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
12.88K
+69.56%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
业务USD
名称
营收
占比
DSA
592.61M
60.21%
RMS
213.07M
21.65%
Manufacturing
178.49M
18.14%
地区USD
名称
营收
占比
United States
536.96M
54.56%
Europe
263.25M
26.75%
Canada
125.35M
12.74%
Asia Pacific (Region)
41.94M
4.26%
Other
16.67M
1.69%
业务
地区
业务USD
名称
营收
占比
DSA
592.61M
60.21%
RMS
213.07M
21.65%
Manufacturing
178.49M
18.14%
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.41%
Wellington Management Company, LLP
8.72%
BlackRock Institutional Trust Company, N.A.
5.92%
UBS Financial Services, Inc.
4.86%
Allspring Global Investments, LLC
4.66%
Other
63.42%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.41%
Wellington Management Company, LLP
8.72%
BlackRock Institutional Trust Company, N.A.
5.92%
UBS Financial Services, Inc.
4.86%
Allspring Global Investments, LLC
4.66%
Other
63.42%
股东类型
持股股东
占比
Investment Advisor
51.51%
Investment Advisor/Hedge Fund
40.20%
Hedge Fund
7.75%
Research Firm
7.62%
Pension Fund
1.84%
Bank and Trust
1.48%
Sovereign Wealth Fund
1.10%
Individual Investor
1.05%
Insurance Company
0.08%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1392
55.35M
112.69%
-5.40M
2025Q1
1435
55.38M
112.72%
-5.93M
2024Q4
1423
54.85M
107.26%
-4.35M
2024Q3
1392
53.78M
105.14%
-5.12M
2024Q2
1399
54.00M
104.84%
-4.00M
2024Q1
1393
53.76M
104.37%
-4.04M
2023Q4
1424
53.56M
104.42%
-4.24M
2023Q3
1446
53.56M
104.42%
-3.98M
2023Q2
1427
52.88M
103.32%
-3.95M
2023Q1
1431
52.72M
103.01%
-2.79M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
6.09M
12.41%
-39.84K
-0.65%
Mar 31, 2025
Wellington Management Company, LLP
4.29M
8.72%
+208.59K
+5.12%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.91M
5.92%
-42.75K
-1.45%
Mar 31, 2025
UBS Financial Services, Inc.
2.39M
4.86%
+2.09M
+702.65%
Mar 31, 2025
Allspring Global Investments, LLC
1.77M
3.61%
-33.40K
-1.85%
Mar 31, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.95M
3.97%
+144.73K
+8.02%
Mar 31, 2025
State Street Global Advisors (US)
1.90M
3.87%
-278.81K
-12.78%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.26M
2.57%
+30.45K
+2.47%
Mar 31, 2025
Impactive Capital LP
1.21M
2.47%
+9.20K
+0.77%
Mar 31, 2025
Ariel Investments, LLC
1.10M
2.24%
+33.45K
+3.13%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
First Trust NASDAQ Pharmaceuticals ETF
1.9%
VanEck Biotech ETF
1.5%
ROBO Global Healthcare Technology & Innovation ETF
1.43%
Invesco S&P 500 Equal Weight Health Care ETF
1.37%
Schwab Ariel ESG ETF
1.35%
Franklin Genomic Advancements ETF
1.33%
Principal Quality ETF
0.92%
Invesco S&P 500 High Beta ETF
0.9%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.78%
iShares Biotechnology ETF
0.72%
查看更多
First Trust NASDAQ Pharmaceuticals ETF
占比1.9%
VanEck Biotech ETF
占比1.5%
ROBO Global Healthcare Technology & Innovation ETF
占比1.43%
Invesco S&P 500 Equal Weight Health Care ETF
占比1.37%
Schwab Ariel ESG ETF
占比1.35%
Franklin Genomic Advancements ETF
占比1.33%
Principal Quality ETF
占比0.92%
Invesco S&P 500 High Beta ETF
占比0.9%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
占比0.78%
iShares Biotechnology ETF
占比0.72%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
